FDA inspection
Xiamen Kang Zhongyuan Biotechnology Co., Ltd.: FDA inspection ending Aug 15, 2025
FDA inspection 1281150 · Official Action Indicated (OAI) · Xiamen
Key facts
| Inspection ID | 1281150 |
|---|---|
| Firm | Xiamen Kang Zhongyuan Biotechnology Co., Ltd. |
| FEI number | 3027976266 |
| Address | No. 2018, 2 Jietou Road |
| City | Xiamen |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Aug 15, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 719320 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data